BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 26055202)

  • 21. Antidepressant-like effect of geniposide on chronic unpredictable mild stress-induced depressive rats by regulating the hypothalamus-pituitary-adrenal axis.
    Cai L; Li R; Tang WJ; Meng G; Hu XY; Wu TN
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1332-41. PubMed ID: 25914157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stress responsive neurohormones in depression and anxiety.
    Ströhle A; Holsboer F
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dexamethasone corticotropin releasing hormone test in healthy and depressed women with and without childhood adversity.
    Spitzer C; Otte C; Kuehl LK; May A; Schultebraucks K; Hellmann-Regen J; Wingenfeld K
    Psychoneuroendocrinology; 2018 Jan; 87():147-151. PubMed ID: 29080551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corticotropin-releasing hormone system polymorphisms are associated with children's cortisol reactivity.
    Sheikh HI; Kryski KR; Smith HJ; Hayden EP; Singh SM
    Neuroscience; 2013 Jan; 229():1-11. PubMed ID: 23131710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasopressin as a target for antidepressant development: an assessment of the available evidence.
    Scott LV; Dinan TG
    J Affect Disord; 2002 Nov; 72(2):113-24. PubMed ID: 12200202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of corticotropin-releasing hormone receptor1 gene SNP and haplotype with major depression.
    Liu Z; Zhu F; Wang G; Xiao Z; Wang H; Tang J; Wang X; Qiu D; Liu W; Cao Z; Li W
    Neurosci Lett; 2006 Sep; 404(3):358-62. PubMed ID: 16815632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E; Schmid D; Modell S; Brunner H; Lauer CJ; Holsboer F; Ising M
    J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attenuation of HPA axis hyperactivity and simultaneous clinical deterioration in a depressed patient treated with mirtazapine.
    Schüle C; Baghai T; Zwanzger P; Rupprecht R
    World J Biol Psychiatry; 2001 Apr; 2(2):103-5. PubMed ID: 12587193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations between cognitive performance and cortisol reaction to the DEX/CRH test in patients recovered from depression.
    Behnken A; Bellingrath S; Symanczik JP; Rieck MJ; Zavorotnyy M; Domschke K; Arolt V; Zwanzger P
    Psychoneuroendocrinology; 2013 Mar; 38(3):447-54. PubMed ID: 22840287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions.
    Aihara M; Ida I; Yuuki N; Oshima A; Kumano H; Takahashi K; Fukuda M; Oriuchi N; Endo K; Matsuda H; Mikuni M
    Psychiatry Res; 2007 Aug; 155(3):245-56. PubMed ID: 17587554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms in the BDNF and BDNFOS genes are associated with hypothalamus-pituitary axis regulation in major depression.
    Hennings JM; Kohli MA; Uhr M; Holsboer F; Ising M; Lucae S
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109686. PubMed ID: 31295515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attenuation of hypothalamic-pituitary-adrenocortical hyperactivity in depressed patients by mirtazapine.
    Schüle C; Baghai T; Zwanzger P; Ella R; Eser D; Padberg F; Möller HJ; Rupprecht R
    Psychopharmacology (Berl); 2003 Mar; 166(3):271-5. PubMed ID: 12552362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypothalamic-pituitary-adrenocortical axis dysregulation in patients with major depression is influenced by the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene.
    Baghai TC; Schule C; Zwanzger P; Minov C; Zill P; Ella R; Eser D; Oezer S; Bondy B; Rupprecht R
    Neurosci Lett; 2002 Aug; 328(3):299-303. PubMed ID: 12147330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corticotropin-releasing hormone and the hypothalamic-pituitary-adrenal axis in psychiatric disease.
    Naughton M; Dinan TG; Scott LV
    Handb Clin Neurol; 2014; 124():69-91. PubMed ID: 25248580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
    Ströhle A
    Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.
    Tsai SJ; Hong CJ; Liou YJ; Chen TJ; Chen ML; Hou SJ; Yen FC; Yu YW
    Psychiatry Res; 2009 Sep; 169(2):113-7. PubMed ID: 19700204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mice selected for extremes in stress reactivity reveal key endophenotypes of major depression: a translational approach.
    Heinzmann JM; Kloiber S; Ebling-Mattos G; Bielohuby M; Schmidt MV; Palme R; Holsboer F; Uhr M; Ising M; Touma C
    Psychoneuroendocrinology; 2014 Nov; 49():229-43. PubMed ID: 25123105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular changes associated with escitalopram response in a stress-based model of depression.
    Benatti C; Alboni S; Blom JMC; Mendlewicz J; Tascedda F; Brunello N
    Psychoneuroendocrinology; 2018 Jan; 87():74-82. PubMed ID: 29049934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study.
    Kunugi H; Ida I; Owashi T; Kimura M; Inoue Y; Nakagawa S; Yabana T; Urushibara T; Kanai R; Aihara M; Yuuki N; Otsubo T; Oshima A; Kudo K; Inoue T; Kitaichi Y; Shirakawa O; Isogawa K; Nagayama H; Kamijima K; Nanko S; Kanba S; Higuchi T; Mikuni M
    Neuropsychopharmacology; 2006 Jan; 31(1):212-20. PubMed ID: 16123748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.